# Iron Galactarate **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/iron-galactarate **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-01 **Evidence Score:** 2 / 10 **Category:** Mineral **Also Known As:** Iron galactrate, Galactaric acid iron salt, Iron(II) galactarate, Iron mucate, Ferrous galactarate, Iron galactaronic acid salt ## Overview Iron galactarate is an iron salt formed by binding ferric or ferrous iron to galactaric acid (mucic acid), a dicarboxylic sugar acid derived from galactose oxidation. No clinical trials have evaluated its efficacy or bioavailability in humans, leaving its therapeutic potential entirely theoretical. ## Health Benefits • No clinically proven health benefits - no human trials exist • Potential metal chelation properties based on chemical structure only • May theoretically support iron supplementation - no evidence available • Galactarate component is a human metabolite - significance unknown • No documented therapeutic effects in available research ## Mechanism of Action Iron galactarate theoretically delivers elemental iron through dissociation of the iron-galactarate salt complex in the acidic gastric environment, releasing free iron ions for absorption via duodenal enterocyte transporters such as divalent metal transporter 1 (DMT1). The galactarate ligand, a fully oxidized six-carbon sugar acid, may act as a chelating agent coordinating iron through its two terminal carboxylate groups, potentially influencing solubility and redox behavior. Whether this coordination chemistry confers any absorption advantage over established iron salts like ferrous sulfate or ferric bisglycinate remains entirely speculative in the absence of pharmacokinetic data. ## Clinical Summary As of the current date, zero published human clinical trials, animal studies, or pharmacokinetic investigations exist specifically examining iron galactarate. No randomized controlled trials, open-label studies, or case series have evaluated its efficacy for iron deficiency anemia, bioavailability relative to standard iron supplements, or any other health outcome. The only basis for any claims is inference from iron biochemistry and the known metabolic role of galactaric acid as an endogenous human metabolite. Evidence strength is rated negligible, and no dosing conclusions can be responsibly drawn. ## Nutritional Profile Iron Galactarate is an iron salt of D-galactaric acid (mucic acid), with an approximate molecular formula of Fe(C₆H₈O₈)·xH₂O. It provides elemental iron (Fe²⁺/Fe³⁺), typically yielding ~10-15% elemental iron by weight depending on hydration state. The galactarate (mucate) ligand is a sugar acid derived from galactose oxidation and is a naturally occurring human metabolite found in trace amounts. No significant vitamin, fiber, or protein content. The organic acid chelation of iron may theoretically enhance bioavailability compared to inorganic iron salts (e.g., ferrous sulfate) by improving solubility at intestinal pH and reducing free iron-mediated [oxidative stress](/ingredients/condition/antioxidant) in the GI tract, though no absorption studies specific to iron galactarate have been published. No standardized dietary reference values exist for this compound. ## Dosage & Preparation No clinically studied dosage ranges exist for iron galactarate. No forms (extract, powder, standardized) have been evaluated in human trials. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions No formal safety studies, toxicology reports, or adverse event data exist for iron galactarate specifically, making it impossible to establish a verified safety profile. General iron supplementation risks such as gastrointestinal irritation, nausea, constipation, and iron overload in susceptible individuals (e.g., those with hemochromatosis) would theoretically apply. Iron in any form can interact with tetracycline antibiotics, fluoroquinolones, levothyroxine, and bisphosphonates by forming insoluble chelate complexes that reduce drug absorption. Pregnant or breastfeeding individuals and those with hemoglobinopathies or [inflammatory](/ingredients/condition/inflammation) bowel disease should avoid unstudied iron compounds and consult a physician before use. ## Scientific Research No human clinical trials, randomized controlled trials (RCTs), or meta-analyses were identified for iron galactarate. No PubMed PMIDs are available as no biomedical studies on its efficacy or safety in humans appear in the research. Available information is limited to chemical properties and non-clinical patent data. ## Historical & Cultural Context No historical or traditional medicinal uses of iron galactarate or galactaric acid are documented. Galactaric acid is noted solely as a human metabolite and chemical precursor without ties to traditional medicine systems. ## Synergistic Combinations Pairs well with Vitamin C (ascorbic acid, 100-200 mg), which reduces Fe³⁺ to the more absorbable Fe²⁺ form and maintains iron solubility in the alkaline duodenum, significantly enhancing non-heme iron absorption. Vitamin B12 (methylcobalamin, 500-1000 µg) and Folate (5-MTHF, 400 µg) synergize with iron by supporting complementary steps in erythropoiesis—B12 and folate are required for DNA synthesis in red blood cell precursors, while iron is essential for hemoglobin production, making this a classic hematologic support stack. Copper (as copper bisglycinate, 1-2 mg) should be included as it is required for ceruloplasmin activity, which oxidizes Fe²⁺ to Fe³⁺ for loading onto transferrin, and chronic iron supplementation without adequate copper can impair iron mobilization. Lactoferrin (100-200 mg) may further enhance iron uptake via receptor-mediated endocytosis in intestinal enterocytes independent of the DMT1 pathway. ## Frequently Asked Questions ### What is iron galactarate used for? Iron galactarate has no established or clinically proven uses. It is an iron salt theoretically capable of delivering elemental iron, but no human trials have tested it for iron deficiency, anemia, or any other condition. Its presence in some supplement contexts appears to be based solely on its chemical classification as an iron compound. ### Is iron galactarate better absorbed than ferrous sulfate? There is no pharmacokinetic or bioavailability data comparing iron galactarate to ferrous sulfate or any other iron form. Ferrous sulfate has well-documented absorption rates of approximately 10–20% in non-deficient adults and remains the reference standard. Any claim that iron galactarate offers superior absorption would be entirely unsupported by evidence. ### What is galactaric acid and why is it paired with iron? Galactaric acid, also called mucic acid, is a symmetric dicarboxylic acid produced by the oxidation of galactose and is recognized as a normal human metabolite. Its two carboxylate end groups can coordinate metal ions like iron, which is the likely chemical rationale for forming an iron galactarate salt. Whether this pairing confers any biological advantage over simpler iron salts has never been experimentally tested. ### Are there any side effects of iron galactarate? No side effect data specific to iron galactarate exists in published literature. By extrapolation from iron pharmacology, common side effects of iron supplementation generally include nausea, constipation, dark stools, and abdominal cramping, which are often dose-dependent. Until dedicated safety studies are conducted, the full adverse effect profile of iron galactarate cannot be determined. ### How does iron galactarate compare to iron bisglycinate? Iron bisglycinate (ferrous bisglycinate chelate) is a well-studied amino acid chelated iron form with multiple human clinical trials demonstrating improved tolerability and absorption of approximately 25–90% relative to ferrous sulfate in various populations. Iron galactarate, by contrast, has zero clinical studies and no established bioavailability data. From an evidence-based standpoint, iron bisglycinate is substantially better supported for supplementation purposes. ### What does research quality show about iron galactarate's effectiveness? Currently, no human clinical trials have been conducted on iron galactarate, making it impossible to establish proven efficacy or safety profiles in real-world use. Available evidence is limited to chemical structure analysis and theoretical properties based on its galactarate chelation component. Any health claims about iron galactarate remain unsubstantiated until rigorous human studies are completed. ### Who should avoid iron galactarate supplementation? Because no safety studies exist on iron galactarate, it should be avoided by pregnant women, nursing mothers, and children without medical supervision. Individuals with hemochromatosis or other iron overload disorders should not use iron galactarate without consulting a healthcare provider, as the chelation properties remain untested in these populations. People taking medications that interact with iron supplements should consult their doctor before use. ### How much iron galactarate should I take and when? No established dosage guidelines exist for iron galactarate due to the absence of human clinical trials. Manufacturers may suggest varying doses, but these are not based on clinical evidence of safety or efficacy. It is essential to consult a healthcare provider before taking iron galactarate to determine if supplementation is appropriate and to establish any dosing recommendations. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*